Showing results (1-10 of 178) with videos related to
Sort By:
Pageof 18
Arthritis Research & Therapy|October 5, 2010
The increased cardiovascular risk in rheumatoid arthritis: when does it start?Michael T NurmohamedExpert Review of Cardiovascular Therapy|April 27, 2011
Cardiovascular risk in rheumatoid arthritis: when does it really start?Michael T NurmohamedDrugs|October 2, 2009
Newer biological agents in the treatment of rheumatoid arthritis: do the benefits outweigh the risks?Michael T NurmohamedVascular Health and Risk Management|January 19, 2008
Atherogenic lipid profiles and its management in patients with rheumatoid arthritisMichael T NurmohamedBMC Medicine|March 20, 2014
Biologics, cardiovascular effects and cancerNemanja Damjanov, Michael T Nurmohamed, Zoltán SzekaneczDrugs|March 8, 2005
Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritisMichael T Nurmohamed, Ben A C DijkmansArthritis Research & Therapy|October 3, 2008
Are biologics more effective than classical disease-modifying antirheumatic drugs?Michael T Nurmohamed, Ben A C DijkmansArthritis Research & Therapy|March 22, 2013
Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?Mike J L Peters, Michael T NurmohamedJournal of Clinical Medicine|May 28, 2022
Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022Bas Dijkshoorn, Reinder Raadsen, Michael T NurmohamedPageof 18